Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous CIK Cells for Solid Tumors
NCT01868490Phase 2Enrolling by invitation
- Sponsor
- Siriraj Hospital
- Start
- Apr 2009
- Primary completion
- Jan 2028
- Modality
- Allogeneic CAR-T, Tumor-Infiltrating Lymphocytes (TILs), TCR-Engineered T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of unmodified CIK in cholangiocarcinoma (CCA), neuroblastoma, sponsored by Siriraj Hospital. Started Apr 2009; status: enrolling by invitation.
02
Drugs
unmodified CIK
03
Conditions
cholangiocarcinoma (CCA)neuroblastoma
Beyond the preview
Go deeper on NCT01868490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01868490.